SEK26.05
0.38% today
Stockholm, Aug 05, 04:19 pm CET
ISIN
SE0002485979
Symbol
GENO

Genovis Stock price

SEK26.15
-2.65 9.20% 1M
+0.25 0.97% 6M
+1.45 5.87% YTD
-1.10 4.04% 1Y
-30.55 53.88% 3Y
-9.60 26.85% 5Y
+24.10 1,175.61% 10Y
-80.85 75.56% 20Y
Stockholm, Closing price Mon, Aug 04 2025
-0.50 1.88%

Key metrics

Basic
Market capitalization
SEK1.8b
Enterprise Value
SEK1.7b
Net debt
positive
Cash
SEK175.4m
Shares outstanding
65.5m
Valuation (TTM | estimate)
P/E
72.6 | 57.0
P/S
14.4 | 12.2
EV/Sales
13.6 | 11.5
EV/FCF
56.0
P/B
7.6
Financial Health
Equity Ratio
69.6%
Return on Equity
14.4%
ROCE
11.9%
ROIC
-
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
SEK122.6m | SEK144.3m
EBITDA
SEK46.5m | SEK46.9m
EBIT
SEK36.3m | SEK38.3m
Net Income
SEK23.6m | SEK30.1m
Free Cash Flow
SEK29.7m
Growth (TTM | estimate)
Revenue
-3.5% | 10.7%
EBITDA
24.3% | 17.6%
EBIT
36.1% | 29.9%
Net Income
-23.0% | -8.7%
Free Cash Flow
-24.8%
Margin (TTM | estimate)
Gross
62.6%
EBITDA
37.9% | 32.5%
EBIT
29.6%
Net
19.3% | 20.8%
Free Cash Flow
24.2%
More
EPS
SEK0.4
FCF per Share
SEK0.5
Short interest
-
Employees
32
Rev per Employee
SEK4.1m
Show more

Is Genovis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,032 stocks worldwide.

Genovis Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Genovis forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Genovis forecast:

Buy
88%
Hold
13%

Financial data from Genovis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
123 123
3% 3%
100%
- Direct Costs 46 46
6% 6%
37%
77 77
9% 9%
63%
- Selling and Administrative Expenses 43 43
9% 9%
35%
- Research and Development Expense - -
-
-
47 47
24% 24%
38%
- Depreciation and Amortization 10 10
5% 5%
8%
EBIT (Operating Income) EBIT 36 36
36% 36%
30%
Net Profit 24 24
23% 23%
19%

In millions SEK.

Don't miss a Thing! We will send you all news about Genovis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Genovis AB engages in the research and development of enzyme products. Its product portfolio includes SmartEnzymes, which offers to pharmaceutical and medical device industries tools that facilitate the development of new treatment methods and diagnostics. The company was founded by Inga Sarah Maria Fredriksson in 1999 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Mr. Olsson
Employees 32
Founded 1999
Website www.genovis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today